A Single Center Study on Comparing the Different Function of EndoAngel in Improving the Quality of Colonscopy

NCT ID: NCT04453956

Last Updated: 2020-10-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1090 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-01

Study Completion Date

2020-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An artificial intelligence-based system, named EndoAngel,has been constructed previously,which has polyp detection and quality monitoring functions. This study aims to evaluate the two different functions of EndoAngle in improving adenoma detection rate.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The detection and removal of precancerous polyps via colonoscopy can reduce the the risk of colon cancer. However, the detection rate of adenomatous polyps can vary significantly among endoscopists. EndoAngel is an artificial intelligence-based system,consisting of polyp detection and quality monitoring functions. The polyp detection function can remind endoscopists of the location of the polyp. The quality monitoring function can monitor the velocity of insertion of the endoscope, record the time of insertion and withdrawal of the endoscope, and remind endoscopists of the blind areas caused by intestinal segment slipping.This study aims to evaluate the two different functions of EndoAngle by 2 × 2 factorial design in improving adenoma detection rate and the quality of colonscopy .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adenoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Patients will receive colonoscopy without assistance of EndoAngel's any function.

Group Type SHAM_COMPARATOR

Colonoscopy without the assistance of EndoAngel's any function.

Intervention Type DIAGNOSTIC_TEST

Patient in this group will receive colonoscopy with assistance of EndoAngel's both functions.

Polyp detection function group

Patients will receive colonoscopy with the assistance of EndoAngel's polyp detection function.

Group Type EXPERIMENTAL

Colonoscopy with the assistance of EndoAngel's polyp detection function.

Intervention Type DIAGNOSTIC_TEST

Patient in this group will receive colonoscopy with assistance of EndoAngel's polyp detection function,which can remind endoscopists of the location of the polyp.

Quality monitoring function group

Patients will receive colonoscopy with the assistance of EndoAngel's quality monitoring function.

Group Type EXPERIMENTAL

Colonoscopy with the assistance of EndoAngel's quality monitoring function.

Intervention Type DIAGNOSTIC_TEST

Patient in this group will receive colonoscopy with assistance of EndoAngel's quality monitoring function,which can monitor the withdrawal speed of the endoscope.

Polyp detection plus quality monitoring functions group

Patients will receive colonoscopy with the assistance of EndoAngel's polyp detection plus quality monitoring function.

Group Type EXPERIMENTAL

Colonoscopy with the assistance of EndoAngel's polyp detection function.

Intervention Type DIAGNOSTIC_TEST

Patient in this group will receive colonoscopy with assistance of EndoAngel's polyp detection function,which can remind endoscopists of the location of the polyp.

Colonoscopy with the assistance of EndoAngel's quality monitoring function.

Intervention Type DIAGNOSTIC_TEST

Patient in this group will receive colonoscopy with assistance of EndoAngel's quality monitoring function,which can monitor the withdrawal speed of the endoscope.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Colonoscopy with the assistance of EndoAngel's polyp detection function.

Patient in this group will receive colonoscopy with assistance of EndoAngel's polyp detection function,which can remind endoscopists of the location of the polyp.

Intervention Type DIAGNOSTIC_TEST

Colonoscopy with the assistance of EndoAngel's quality monitoring function.

Patient in this group will receive colonoscopy with assistance of EndoAngel's quality monitoring function,which can monitor the withdrawal speed of the endoscope.

Intervention Type DIAGNOSTIC_TEST

Colonoscopy without the assistance of EndoAngel's any function.

Patient in this group will receive colonoscopy with assistance of EndoAngel's both functions.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female aged 18 years or above;
2. Colonoscopy is needed to further characterize gastrointestinal diseases;
3. Ability to read, understand and sign informed consent forms;
4. The researchers believe that the subjects can understand the process of the clinical study and are willing and able to complete all the study procedures and follow-up visits to cooperate with the study procedures.

Exclusion Criteria

1. Participated in other clinical trials, signed informed consent forms and followed up in other clinical trials;
2. Participate in a drug clinical trial and during the elution period of the trial or control drug;
3. Drug or alcohol abuse or mental disorder in the last 5 years;
4. Pregnant or lactating women;
5. Patients with multiple polyp syndrome;
6. Patients with a history of inflammatory bowel disease, colorectal cancer, or colorectal surgery;
7. Patients with known perforation or colonic obstruction;
8. Patients with a contraindication for biopsy;
9. The researchers did not consider the subjects suitable for colonoscopy;
10. The researchers determined that the subjects had high-risk diseases or other special conditions that were not appropriate for clinical trials.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Renmin Hospital of Wuhan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Renmin Hospital of Wuhan University

Wuhan, Hubei, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Honggang Yu, MD

Role: CONTACT

+8613871281899

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Honggang Yu, MD

Role: primary

+8613871281899

References

Explore related publications, articles, or registry entries linked to this study.

Yao L, Zhang L, Liu J, Zhou W, He C, Zhang J, Wu L, Wang H, Xu Y, Gong D, Xu M, Li X, Bai Y, Gong R, Sharma P, Yu H. Effect of an artificial intelligence-based quality improvement system on efficacy of a computer-aided detection system in colonoscopy: a four-group parallel study. Endoscopy. 2022 Aug;54(8):757-768. doi: 10.1055/a-1706-6174. Epub 2022 Feb 4.

Reference Type DERIVED
PMID: 34823258 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EA-19-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.